Serum Institute gets nod to resume vaccine trial in India

Drugs Controller General of India Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while......

Uzbek syrup deaths: India begins probe, manufacturing halted

The manufacturing of Marion Biotech's Dok-1 Max has stopped “for now”, the company's legal representative said on Thursday as the Central Drugs Standard Control Organisation began a......

Serum Inst gets DGCI notice over continuation of vaccine trial

The central drug regulator has issued a show-cause notice to the Serum Institute of India (SII) for not informing it about pharma giant AstraZeneca pausing the clinical trials of the Oxford vaccine......

V G Somani: The head of DCGI known as man of actions, not of words

'Safety is my first priority.''I need to ensure that any drug or vaccine that our citizens get is first safe.'Drug Controller General of India Dr V G Somani is a man of action, discovers Sohini......